Clinical trial
A Phase Ⅲ Clinical Trial for Efficacy, Immunogenicity, Safety and Immune Persistence of Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children Aged From 6-15 Years Old.
NCT02302170 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase Ⅲ Clinical Trial for Efficacy, Immunogenicity, Safety and Immune Persistence of Oral Recombinant Helicobacter Pylori Vaccine in Chinese Children Aged From 6-15 Years Old.
- Lead sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2004
- Completion date
- September 30, 2008
- Enrollment
- 4,464 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
h. pylori infection